Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
GoodRx Holdings (GDRX)
NASDAQ:GDRX
Holding GDRX?
Track your performance easily
GDRX Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$4.09 - $9.26
Previous Close$4.52
Volume842.76K
Average Volume (3M)1.38M
Market Cap
$1.72B
Enterprise Value$1.84B
Total Cash (Recent Filing)$423.78M
Total Debt (Recent Filing)$544.57M
Price to Earnings (P/E)―
Beta1.08
Next Earnings
Feb 26, 2025EPS Estimate
$0.1Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.04
Shares Outstanding381,142,196
10 Day Avg. Volume1,279,318
30 Day Avg. Volume1,379,502
Standard Deviation0.19
R-Squared0.10
Alpha-0.05
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)2.47
Price to Sales (P/S)2.17
Price to Cash Flow (P/CF)4.90
P/FCF Ratio6.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue2.33
Enterprise Value/Gross Profit2.70
Enterprise Value/Ebitda22.23
Forecast
1Y Price Target
$7.15Price Target Upside54.76% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering15
GoodRx Holdings News
PremiumCompany Announcements
GoodRx Holdings Appoints Wendy Barnes as CEO
Bulls Say, Bears Say
Bulls Say
Growth PotentialThe Manufacturer Solutions segment is expected to grow 20%+ annually over the next few years, as GoodRx penetrates a serviceable addressable market for digital marketing solutions for branded drug manufacturers.
LeadershipThe appointment of Wendy Barnes as GoodRx's new CEO is seen as an incremental positive due to her strong and highly relevant experience in leadership roles at Express Scripts and Rite Aid.
Strategic InitiativesWendy Barnes will focus on advancing GoodRx's strategic initiatives, enhancing product experience, and improving relationships with key stakeholders.
Bears Say
Leadership And Growth TrajectoryThe unexpected nature of the CEO announcement likely adds some near-term uncertainty to the growth narrative.
Retail Environment ImpactStore closures announced by several large retail drug chains negatively impact GDRX's outlook, putting its 2026 guidance in jeopardy.
Revenue And Business Model ChallengesGoodRx's historic business model focused on PBM network rates is being disrupted by CVS' new Cost Vantage model.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
GDRX FAQ
What was GoodRx Holdings’s price range in the past 12 months?
GoodRx Holdings lowest stock price was $4.09 and its highest was $9.26 in the past 12 months.
What is GoodRx Holdings’s market cap?
Currently, no data Available
When is GoodRx Holdings’s upcoming earnings report date?
GoodRx Holdings’s upcoming earnings report date is Feb 26, 2025 which is in 60 days.
How were GoodRx Holdings’s earnings last quarter?
GoodRx Holdings released its earnings results on Nov 07, 2024. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.087 by -$0.007.
Is GoodRx Holdings overvalued?
According to Wall Street analysts GoodRx Holdings’s price is currently Undervalued.
Does GoodRx Holdings pay dividends?
GoodRx Holdings does not currently pay dividends.
What is GoodRx Holdings’s EPS estimate?
GoodRx Holdings’s EPS estimate is $0.1.
How many shares outstanding does GoodRx Holdings have?
GoodRx Holdings has 104,272,870 shares outstanding.
What happened to GoodRx Holdings’s price movement after its last earnings report?
GoodRx Holdings reported an EPS of $0.08 in its last earnings report, missing expectations of $0.087. Following the earnings report the stock price went down -17.512%.
Which hedge fund is a major shareholder of GoodRx Holdings?
Among the largest hedge funds holding GoodRx Holdings’s share is Silver Lake Group, L.L.C.. It holds GoodRx Holdings’s shares valued at 25M.
---
GoodRx Holdings Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$7.15 (54.76% Upside)
$7.15 (54.76% Upside)
Blogger Sentiment
Neutral
GDRX Sentiment 50%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 969.8K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.6%
Last 30 Days ▼ 1.9%
Last 30 Days ▼ 1.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-29.81%
12-Months-Change
Fundamentals
Return on Equity
-2.06%
Trailing 12-Months
Asset Growth
-20.68%
Trailing 12-Months
Company Description
GoodRx Holdings
GoodRx Holdings Inc provides digital healthcare platform that provides prescription drugs at affordable prices. The company offers services like diabetes testing, general visits, blood tests, HIV testing, Vitamin D screening, Pregnancy testing, and many more.
---
GDRX Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook. While there are significant gains in adjusted EBITDA and the pharma manufacturer solutions segment, challenges in the retail pharmacy environment and its impact on prescription transaction revenue remain a concern.Read More>---
GDRX Revenue Breakdown
73.41% Prescription transactions
12.58% Subscription
11.34% Pharma manufacturer solutions
2.67% Other
---
GDRX Stock 12 Month Forecast
Average Price Target
$7.15
▲(54.76% Upside)
Technical Analysis
Best Analysts Covering GDRX
1 Year
1 Year Success Rate
9/9 ratings generated profit
1 Year Average Return
+22.22%
reiterated a sell rating 12 days ago
Copying Allen Lutz's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +22.22% per trade.
---